The VA has denied the veteran's claims for increased ratings for adenocarcinoma of the prostate and impotence, both rated as noncompensable since the effective date of service connection.
The deciding factor: The medical evidence did not show recurrence or metastasis of the conditions, and the residuals were evaluated under criteria that did not support higher ratings based on severity of symptoms.
- Claimed conditions
- adenocarcinoma of the prostate, impotence
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- May 27, 2003
- Citation
- 0310168
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 0310168.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board remands the claims for service connection for diabetes mellitus, hypertension, adenocarcinoma of the prostate, and erectile dysfunction due to inadequate toxic exposure risk activities (TERA) memoranda and a need for additional medical opinions.
- Denied
The Board denied the veteran's claims for increased ratings for various conditions, including impotence, headaches, cervical spine degenerative joint disease, and peripheral neuropathy of both upper and lower extremities.
- Remanded (sent back)
The Board remands the claims for service connection for a respiratory condition, diabetes, high blood pressure, sleep apnea, and impotence to ensure VA satisfies its duty to assist by providing the Veteran with VA examinations.
- Partly granted
The Veteran was granted a total 100 percent rating for adenocarcinoma of the prostate, beginning February 26, 2018, due to a PSA level above 4.0 indicating local recurrence.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.